Hyaluronate derivatives in drug delivery

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 15, Issue 5, 1998, Pages 513-555

  Vercruysse, Koen P ^a   Prestwich, Glenn D ^a   Kuo, Jing Wen ^b  

^a UNIVERSITY OF UTAH   (United States)

^b Anika Therapeutics   (United States)

Author keywords

Biomaterial; Chemical modification; Drug targeting; Glycosaminoglycan; Polysaccharide

Indexed keywords

ALPHA INTERFERON; BIOMATERIAL; CARBOXYMETHYLCELLULOSE; COLLAGEN; GANGLIOSIDE GM1; HYALURONIC ACID; HYALURONIC ACID DERIVATIVE; HYANALGESE; HYDAK; HYDROCORTISONE; HYDROXYAPATITE; HYLASHIELD; HYLUCARE; HYVISC; METHYLPREDNISOLONE; MICROSPHERE; NERVE GROWTH FACTOR; OSSIGEL; POLYACRYLIC ACID; POLYMER; POLYSACCHARIDE; POLYVINYL ALCOHOL; UNCLASSIFIED DRUG;

ADHESION; BIOCOMPATIBILITY; BIODEGRADATION; CHEMICAL MODIFICATION; CROSS LINKING; DIFFUSION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TARGETING; MUCOSA; PHYSICAL CHEMISTRY; REVIEW; TISSUE SPECIFICITY;

EID: 0031762216     PISSN: 07434863     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevtherdrugcarriersyst.v15.i5.30     Document Type: Review

References (142)

1. Laurent, T. C. and Fraser, J. R. E., Hyaluronan, FASEB J., 6, 2397, 1992.
2. Geciova, R., Flaibani, A., Delben, F., Liut, G., Urbani, R., and Cesaro, A., Physico-chemical properties of hyaluronan and its Hydrophobic derivatives: A calorimetric and viscometric study, Macromol. Chem. Phys., 196, 2891, 1995.
3. Scott, J. E., Secondary structures in hyaluronan solutions: Chemical and biological implications, in The Biology of Hyaluronan, Foundation, C., Ed., Chichester, UK:Wiley, 1989, 6.
4. Fraser, J. R. E., Laurent, T. C., and Laurent, U. B. G., Hyaluronan: Its nature, distribution, functions, and turnover, J. Intern. Med., 242, 27, 1997.
5. Entwistle J., Hall, C. L., and Turley, E. A., Receptors: Regulators of signalling to the cytoskeleton, J. Cell Biochem., 61, 569, 1996.
6. Toole, B. P., Hyaluronan in morphogenesis, J. Intern. Med., 242, 35, 1997.
7. Delpech, B., Girard, N., Bertrand, P., Courel, M.N., Chauzy, C., and Delpech, A., Hyaluronan: Fundamental principles and applications in cancer, J. Intern. Med., 242, 41, 1997.
8. Gerdin, B. and Hallgren, R., Dynamic role of hyaluronan (HYA) in connective tissue activation and inflammation, J. Intern. Med., 242, 49, 1997.
9. Drobnik, J., Hyaluronan in drug delivery, Adv. Drug Delivery Rev., 7, 295, 1991.
10. Balazs, E. A. and Denlinger J. L., Clinical uses of hyaluronan, in The Biology of Hyaluronan, Evered, D. and Whelan, J., Eds., Chichester, Sussex, UK: Wiley, 1989, 265.
11. Balazs, E. A., Leshchiner, E., Larsen, N., and Band, P., Hyaluronan biomaterials: Medical applications, in Encyclopedic Handbook of Biomaterials and Bioengineering, Part A: Materials, Wise, D. L., Trantolo, D. J., Altobelli, D. E., Yaszemski, M. J., Gresser J. D., and Schwartz, E. R., Eds., New York: Marcel Dekker, 1995, 2719.
12. Willoughby, D. A., Ed., First International Workshop on Hyaluronan in Drug Delivery, London: Royal Society of Medicine Press, 1992.
13. Willoughby, D. A., Ed., Second International Workshop on Hyaluronan in Drug Delivery, London: Royal Society of Medicine Press, 1994.
14. Willoughby, D. A., Ed., Third International Workshop on Hyaluronan in Drug Delivery, London: Royal Society of Medicine Press, 1995.
15. Willoughby, D. A., Ed., Fourth International Workshop on Hyaluronan in Drug Delivery, London: Royal Society of Medicine Press, 1996.
16. Gustafson, S., Hyaluronan in drug delivery, in The Chemistry, Biology, and Medical Applications of Hyaluronan and its Derivatives, T. C. Laurent and E. A. Balazs, Eds., London: Portland Press, 1997.
17. Saettone, M. F., Giannaccini, B., Chetoni, P., Torracca, M. T., and Monti, D., Evaluation of high- and low-molecular-weight fractions of sodium hyaluronate and an ionic complex as adjuvants for topical ophthalmic vehicles containing pilocarpine, Int. J. Pharm., 72, 131, 1991.
18. Morimoto, K.,Yamaguchi, H., Iwakura, Y., Morisaka, K., Ohashi, Y., and Nakai, Y., Effects of viscous hyaluronate-sodium solutions on the nasal absorption of vasopressin and an analogue, Pharm. Res., 8, 471, 1991.
19. Moore, A. R. and Willoughby, D. A., Hyaluronan as a drug delivery system for diclofenac: A hypothesis for mode of action, Int. J. Tissue Reac., 17, 153, 1995.
20. Miller, J. A., Ferguson, R. L., Powers, D. L., Burns, J. W., and Shalaby, S. W., Efficacy of hyaluronic acid/nonsteroidal anti-inflammatory drug systems in preventing postsurgical tendon adhesions, J. Biomed. Mater. Res. (Appl. Biomater.), 38, 25, 1997.
21. Gowland, G., Moore, A. R., Willis, D., and Willoughby, D. A., Marked enhanced efficacy of cyclosporin when combined with hyaluronic acid: Evidence from two T cell-mediated models, Clin. Drug Invest., 11, 245, 1996.
22. Brown, M. B., Marriott, G., and Martin, G. P., The effect of hyaluronan on the in vitro deposition of diclofenac within the skin, Int. J. Tissue Reac., XVII, 133, 1995.
23. Davidson, J. M., Nanney, L. B., Broadley, K. N., Whitsett, J. S., and Aquino, A. M., Hyaluronate derivatives and their application to wound healing: Preliminary observations, Clin. Mater., 8, 171, 1991.
24. Juhlin, L., Hyaluronan in skin, J. Intern. Med., 242, 61, 1997.
25. Sbracia, M., Grasso, J., Sayme, N., Stronk, J., and Huszar, G., Hyaluronic acid substantially increases the retention of motility in cryopreserved/thawed human spermatozoa, Hum. Reprod., 12, 1949, 1997.
26. Assman, V., Kern, H. F., and Elsaesser, H.-P., Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells, Clin. Cancer Res., 2, 1607, 1996.
27. Catterall, J. B., Gardner, M. J., and Turner, G. A., Hyaluronic acid cell adhesion and metastasis, Cancer J., 8, 320, 1995.
28. Ponta, H., Sleeman, J., Dall, P., Moll, J., Sherman, L., and Herrlich, P., CD44 Isoforms in metastatic cancer, Invasion Metastasis, 14, 82, 1994.
29. Tanabe, K. K. and Saya, H., The CD44 adhesion molecule and metastasis, Crit. Rev. Oncog., 5, 201, 1994.
30. Hall, C. L., Yang, B. H., Yang, X. W., Zhang, S.W., Turley, M., Samuel, S., Lange, L. A., Wang, C., Curpen, G. D., Savani, R. C., Greenberg, A. H., and Turley, E. A., Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for Hras transformation, Cell, 82, 19, 1995.
31. Akima, K., Ito, H., Iwata, Y., Matsuo, K., Watari, N., Yanagi, M., Hagi, H., Oshima, K., Yagita, A., Atomi, Y., and Tatekawa, I., Evaluation of antitumor activities of hyaluronate binding antitumor drugs: Synthesis, characterization, and antitumor activity, J. Drug Target., 4, 1, 1996.
32. Gustafson, S. and Bjorkman,T., Circulating hyaluronan, chondroitin sulphate, and dextran sulphate bind to a liver receptor that does not recognize heparin, Glycoconj. J., 14, 561, 1997.
33. Samuelsson, C. and Gustafson, S., Studies on the interaction between hyaluronan and a rat colon cancer cell line, Glycoconj. J., 15, 169, 1998.
34. Prestwich, G. D., Marecak, D.M., Marecek, J. F., Vercruysse, K. P., and Ziebell, M. R., Controlled chemical modification of hyaluronic acid: Synthesis, applications and biodegradation of hydrazide derivatives, J. Controlled Rel., 53, 99, 1998.
35. Cascone, M. G., Sim, B., and Downes, S., Blends of synthetic and natural polymers as drug delivery systems for growth hormone, Biomaterials, 16, 569, 1995.
36. Burns, J. M., Skinner, K., Colt, J., Sheidlin, A., Bronson, R., Yaacobi, Y., and Goldberg, E. P., Prevention of tissue injury and postsurgical adhesions by precoating tissues with hyaluronic acid solutions, J. Surg. Res., 59, 644, 1995.
37. Burns, J. W., Burgess, L., Skinner, K., Rose, R., Colt, M. J., and Diamond, M. P., A hyaluronate based gel for the prevention of postsurgical adhesions: Evaluation in two animal species, Fertil. Steril., 66, 814, 1996.
38. Burns, J. W., Cox, S., and Walts, A. E., US Patent 5,017,229, 1991.
39. Tomihata, K. and Ikada, Y., Crosslinking of hyaluronic acid with water-soluble carbodiimide, J. Biomed. Mater. Res., 37, 243, 1997.
40. Rehakova, M., Bakos, D., Vizarova, K., Soldan, M., and Jurickova, M., Properties of collagen and hyaluronic acid composite materials and their modification by chemical crosslinking, J. Biomed. Mater. Res., 30, 369, 1996.
41. Soldan, M. and Bakos, D., Complex matrix atelocollagen-hyaluronic acid, in Advances in Medical Physics, Biophysics, and Biomaterials, Slovak Republic: Stara Lesna, 1997.
42. Bakos, D., Soldan, M., and Vanis, M., Hydroxyapatite-collagen-hyaluronic acid composite as bone defects filler, in Advances in Medical Physics, Biophysics and Biomaterials, Slovak Republic: Stara Lesna, 1997.
43. Yerushalmi, N., Arad, A., and Margalit, R., Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing, Arch. Biochem. Biophys., 313, 267, 1994.
44. Winnik, F. M. and Pillai, V., Hyaluronan-stabilized colloidal superparamagnetic iron oxides: Preparation and characterization, in 4th International Workshop on Hyaluronan in Drug Delivery, Gressy, France, 1996
45. Kuo, J.-w., Swann, D. A., and Prestwich, G. D., Chemical modification of hyaluronic acid by carbodiimides, Bioconj. Chem., 2, 232, 1991.
46. Kuo, J.-w., Swann, D. A., and Prestwich, G. D., US Patent 5,356,883, 1994.
47. Kuo, J.-w., Swann, D. A., and Prestwich, G.D., US Patent 5,502,081, 1996.
48. Pouyani, T., Kuo, J.-w., Harbison, G. S., and Prestwich, G. D., Solid-state NMR of Nacylureas derived from the reaction of hyaluronic acid with isotopically-labeled carbodiimides, J. Am. Chem. Soc., 114, 5972, 1992.
49. Pouyani, T. and Prestwich, G. D., Functionalized derivatives of hyaluronic acid oligosaccharides: Drug carriers and novel biomaterials, Bioconj. Chem., 5, 339, 1994.
50. Pouyani, T. and Prestwich, G. D., Biotinylated hyaluronic acid: A new tool for probing hyaluronate-receptor interactions, Bioconj. Chem., 5, 370, 1994.
51. Pouyani, T., Harbison, G. S., and Prestwich, G. D., Novel hydrogels of hyaluronic acid: Synthesis, surface morphology, and solid-state NMR, J. Am. Chem. Soc., 116, 7515, 1994.
52. Vercruysse, K. P., Marecak, D. M., Marecek, J. F., and Prestwich, G. D., Synthesis and in vitro degradation of new polyvalent hydrazide cross-linked hydrogels of hyaluronic acid, Bioconj. Chem., 8, 686, 1997.
53. Pouyani, T. and Prestwich, G.D., US Patent 5,616,568, 1997.
54. Pouyani, T. and Prestwich, G. D., US Patent 5,652,347, 1997.
55. Benedetti, L. M., Joshi, H. N., Goei, L., Hunt, J. A., Callegaro, L., Stella, V.J., and Topp, E. M., Dosage forms from polymeric prodrugs: Hydrocortisone esters of hyaluronic acid, New Polymeric Mater., 3, 41, 1991.
56. Hunt, J. A., Joshi, H. N., Stella, V.J., and Topp, E. M., Diffusion and drug release in polymer films prepared from ester derivatives of hyaluronic acid, J. Controlled Rel., 12, 159, 1990.
57. Magnani, A., Albanese, A., Lamponi, S., and Barbucci, R., Blood-interaction performance of differently sulphated hyaluronic acids, Thromb. Res., 81, 383, 1996.
58. Kyyronen, K., Hume, L., Benedetti, L., Urtti, A., Topp, E., and Stella, V., Methylprednisolone esters of hyaluronic acid in ophthalmic drug delivery: In vitro and in vivo release studies, Int. J. Pharm., 80, 161, 1992.
59. Hume, L. R., Topp, E. M., and Stella, V.J., Steroid esters of hyaluronic acid in the treatment of rheumatoid arthritis, Pharm. Res., 7, S-174, 1990.
60. Goei, L., Benedetti, L., Biviano, F., Callegaro, L., Topp, E., and Stella, V., Drug release from hydrocortisone esters of hyaluronic acid: Influence of ester hydrolysis rate on release rate, in 4th International Conference on Polymers in Medicine: Biomedical and Pharmaceutical Applications, Riva del Garda, Italy, 1990
61. Goei, L., Benedetti, L., Topp, E. M., and Stella, V.J., Drug release from hydrocortisone esters of hyaluronic acid, Pharm. Res., 6, S-94, 1989.
62. Benedetti, L. M., Topp, E. M., and Stella, V.J., Microspheres of hyaluronic acid estersfabrication methods and in vitro hydrocortisone release, J. Controlled Rel., 13, 33, 1990.
63. Prestwich, G. D., Marecak, D. M., Marecek, J. F., Vercruysse, K. P., and Ziebell, M. R., Chemical modification of hyaluronic acid for drug delivery, biomaterials, and biochemical probes, in The Chemistry, Biology, and Medical Applications of Hyaluronan and its Derivatives, Laurent, T. C. and Balazs, E. A., Eds., Stockholm: Wenner-Gren Foundation, 1997.
64. Sparer, R. V., Ekwuribe, N., and Walton, A. C., Controlled release from glycosaminoglycan drug complexes, in Controlled Release Delivery Systems, Roseman, T. J. and Mansdorf, S. Z., Eds., New York: Marcel Dekker, 1983, 107.
65. Cera, C., Terbojevich, M., Cosani, A., and Palumbo, M., Anthracycline antibiotics supported on water-soluble polysaccharides: Synthesis and physicochemical characterization, Int. J. Biol. Macromol., 10, 66, 1988.
66. Akima, K., Iwata, Y., Matsuo, K., and Watari, N., European Patent EP 0 506 976 B1, 1992.
67. Sakurai, K., Miyazaki, K., Kodera, Y., Nishimura, H., Shingu, M., and Inada, Y., Anti-inflammatory activity of Superoxide dismutase conjugated with sodium hyaluronate, Glycoconj. J., 14, 723, 1997.
68. Glass, J. R., Dickerson, K. T., Stecker, K., and Polarek, J. W., Characterization of a hyaluronic acid - Arg-Gly-Asp peptide cell attachment matrix, Biomaterials, 17, 1101, 1996.
69. Laurent, T. C., Hellsing, K., and Gelotte, B., Cross-linked gels of hyaluronic acid, Acta Chem. Scand., 18, 274, 1964.
70. Yui, N., Okano, T., and Sakurai, Y., Inflammation responsive degradation of crosslinked hyaluronic acid gels, J. Controlled Rel., 22, 105, 1992.
71. Tomihata, K. and Ikada, Y., Preparation of cross-linked hyaluronic acid films of low water content, Biomaterials, 18, 189, 1997.
72. Cooper, M. L., Hansbrough, J. F., and Polarek, J. W., The effect of an arginine-glycine-aspartic acid peptide and hyaluronate synthetic matrix on epithelialization of meshed skin graft interstices, J. Burn Care Rehabil., 17, 108, 1996.
73. Larsen, N. E. and Balazs, E. A., Drug delivery systems using hyaluronan and its derivatives, Advanced Drug Deliv. Rev., 7, 279, 1991.
74. Shah, C.B. and Baenett, S. M., Hyaluronic acid gels, in Polyelectrolyte Gels: Properties, Preparation, and Applications, Harland, R. S. and Prud'homme, R. K., Eds., Washington, DC: American Chemical Society, 1992, 116.
75. Lowry, K. M. and Beavers, E. M., Resistance of hyaluronate coatings to hyaluronidase, J. Biomed. Mater. Res., 28, 861, 1994.
76. Morra, M. and Cassinelli, C., Wettability and surface structure of hyaluronic acid and hyaluronic acid esters fouling-resistant coatings, in Proceedings of the American Chemical Society Division of Polymeric Materials: Science and Engineering, San Francisco, 1997, 566.
77. Chen, G. P., Ito, Y., Imanishi, Y., Magnani, A., Lamponi, S., and Barbucci, R., Photoimmobilization of sulfated hyaluronic acid for antithrombogenicity, Bioconj. Chem., 8, 730, 1997.
78. Papini, D., Stella, V.J., and Topp, E. M., Diffusion of macromolecules in membranes of hyaluronic acid esters, J. Controlled Rel., 27, 47, 1993.
79. Simon, L. D., Charman, W. N., Charman, S.A., and Stella, V.J., Protein transport across hydrated hyaluronic acid ester membranes: Evaluation of ribonuclease A as a potentially useful model protein, J. Controlled Rel., 45, 273, 1997.
80. Sung, K. C. and Topp, E. M., Effect of drug hydrophilicity and membrane hydration on diffusion in hyaluronic acid esters membranes, J. Controlled Rel., 37, 95, 1995.
81. Demeester, J. and Vercruysse, K. P., Hyaluronidase, in Pharmaceutical Enzymes, Lauwers, A. and Scharpe, S., Eds., New York: Marcel Dekker, 1997, 155.
82. Zhong, S. P., Campoccia, D., Doherty, P.J., Williams, R. L., Benedetti, L., and Williams, D. F., Biodegradation of hyaluronic acid derivatives by hyaluronidase, Biomaterials, 15, 359, 1994.
83. Abatangelo, G., Barbucci, R., Brun, P., and Lamponi, S., Biocompatibility and enzymatic degradation studies on sulphated hyaluronic acid derivatives, Biomaterials, 18, 1411, 1997.
84. Yui, N., Nihira, J., Okano, T., and Sakurai, Y., Regulated release of drug microspheres from inflammation responsive degradable matrices of crosslinked hyaluronic acid, J. Controlled Rel., 25, 133, 1993.
85. Yui, N., Okano, T., and Sakurai, Y., Photo-responsive degradation of heterogeneous hydrogels comprising crosslinked hyaluronic acid and lipid microspheres for temporal drug delivery, J. Controlled Rel., 26, 141, 1993.
86. Park, K., Shalaby, W. S. W., and Park, H., Eds., Biodegradable Hydrogels for Drug Delivery, Technomic Lancaster, PA: Publishing Company, 1993.
87. Cortivo, R., Brun, P., Rastrelli, A., and Abatangelo, G., In vitro studies on biocompatibility of hyaluronic acid esters, Biomaterials, 12, 727, 1991.
88. Andreassi, L., Casini, L., Trabucchi, E., Diamantini, S., Rastrelli, A., Donati, L., Tenchini, M. L., and Malcovati, M., Human keratinocytes cultured on membranes composed of benzyl ester of hyaluronic acid suitable for grafting, Wounds, 3, 116, 1991.
89. Campoccia, D., Hunt, J. A., Doherty, P. J., Zhong, S. P., Callegaro, L., Benedetti, L., and Williams, D. F., Human neutrophil chemokines and polarization induced by hyaluronic acid derivatives, Biomaterials, 14, 1135, 1993.
90. Benedetti, L., Cortivo, R., Berti, T., Berti, A., Pea, F., Mazzo, M., Moras, M., and Abatan-gelo, G., Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats, Biomaterials, 14, 1154, 1993.
91. Campoccia, D., Hunt, J. A., Doherty, P. J., Zhong, S. P., O'Regan, M.,Benedetti, L., and Williams, D. F., Quantitative assessment of the tissue response to films of hyaluronan derivatives, Biomaterials, 17, 963, 1996.
92. Larsen, N. E., Pollak, C. T., Reiner, K., Leschiner, E., and Balazs, E. A., Hylan gel for soft tissue augmentation, in Biotechnology and Bioactive Polymers, Gebelein, C. and Carrahar, C., Eds., New York: Plenum Press, 1994, 25.
93. Larsen, N. E., Leshchiner, E., Pollak, C. T., and Balazs, E. A., Evaluation of Hylan B (Hylan gel) as soft tissue dermal implants, Mat. Res. Soc. Symp. Proc., 394, 193, 1995.
94. Larsen, N. E., Leshchiner, E., and Balazs, E. A., Biocompatibility of Hylan polymers in various tissue compartments, Mat. Res. Soc. Symp. Proc., 394, 149, 1995.
95. Saettone, M. F., Monti, D., Torracca, M. T., and Chetoni, P., Mucoadhesive ophthalmic vehicles: Evaluation of polymeric low-viscosity formulations, J. Ocul. Pharm., 10, 83, 1994.
96. Saettone, M. F., Giannaccini, B., Torracca, M. T., and Burgalassi, S., An evaluation of the bioadhesive properties of hyaluronic acid, in 3rd European Congress of Biopharmaceutics and Pharmacokinetics Proceedings - Volume 1, Biopharmaceutics, Freiburg, Germany: 1987
97. Saettone, M. F., Chetoni, P., Torracca, M. T., Burgalassi, S., and Giannaccini, B., Evaluation of muco-adhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid, Int. J. Pharm., 51, 203, 1989.
98. Sanzgiri, Y. D., Topp, E. M., Benedetti, L., and Stella, V. J., Evaluation of mucoadhesive properties of hyaluronic acid benzyl esters, Int. J. Pharm., 107, 91, 1994.
99. Pritchard, K., Lansley, A. B., Martin, G. P., Helliwell, M., Marriott, C., and Benedetti, L. M., Evaluation of the bioadhesive properties of hyaluronan derivatives: Detachment weight and mucociliary transport rate studies, Int. J. Pharm., 129, 137, 1996.
100. Ghezzo, E., Benedetti, L., Rochira, M., Biviano, F., and Callegaro, L., Hyaluronan derivative microspheres as NGF delivery devices: Preparation methods and in vitro release characterization, Int. J. Pharm., 87, 21, 1992.
101. Rochira, M., Miglietta, M. R., Richardson, J. L., Ferrari, L., Beccaro, M., and Benedetti, L., Novel vaginal delivery systems for calcitonin II: Preparation and characterization of HYAFF microspheres containing calcitonin, Int. J. Pharm., 144, 19, 1996.
102. Gunning, A. P., Morris, V. J., Alssaf, S., and Phillips, G. O., Atomic force microscopic studies of hylan and hyaluronan, Carbohyd. Polym., 30, 1, 1996.
103. Goei, L., Topp, E., Stella, V., Benedetti, L., Biviano, F., and Callegaro, L., Drug release from hydrocortisone esters of hyaluronic acid: Influence of ester hydrolysis rate on release rate, in 4th International Conference on Polymers in Medicine: Biomedical and Pharmaceutical Applications, Riva del Garda, Italy, 1990.
104. Rajewski, L. G., Stinnett, A. A., Stella, V. J., and Topp, E. M., Enzymic and non-enzymic hydrolysis of a polymeric prodrug: Hydrocortisone esters of hyaluronic acid, Int. J. Pharm., 82, 205, 1992.
105. Joshi, H. N., Stella, V. J., and Topp, E. M., Drug release from membranes of hyaluronic acid and its esters, J. Controlled Rel., 20, 109, 1992.
106. Nightlinger, N. S., Benedetti, L., Soranzo, C., Pettit, D. K., Pankey, S. C., and Gombotz, W. R., In vitro release of huGM-CSF from esterified hyaluronic acid microspheres, Proceed. Intern. Symp. Control. Rel. Bioact. Mater., 22, 738, 1995.
107. Prisell, P. T., Camber, O., Hiselius, J., and Norstedt, G., Evaluation of hyaluronan as a vehicle for peptide growth factors, Int. J. Pharm., 85, 51, 1992.
108. Larsen, N. E., Leshchiner, E. A., Parent, E. G., and Balazs, E. A., Hylan and hylan derivatives in drug delivery, in Cosmetic and Pharmaceutical Applications of Polymers, Gebelein, C. G., Ed., New York: Plenum Press, 1991, 147.
109. Podder, S. K., Moy, K. C., and Lee, V. H. L., Improving the safety of topically applied timolol in the pigmented rabbit through manipulation of formulation composition, Exp. Eye Res., 54, 747, 1992.
110. Kay, J. S., Litin, B. S., Woolfenden, J. M., Chvapil, M., and Herschler, J., Delivery of antifibroblast agents as adjuncts to filtration surgery: Part I. Periocular clearance of Cobalt-57 Bleomycin in experimental drug delivery: Pilot study in the rabbit, Ophthalmic Surg, 17, 626, 1986.
111. Nomura, M., Kubota, M. A., Kawamori, R., Yamasaki, Y., Kamada, T., and Abe, H., Effect of addition of hyaluronic acid to highly concentrated insulin on absorption from the conjunctiva in conscious diabetic dogs, J. Pharm. Pharmacol., 46, 768, 1994.
112. Hume, L. R., Lee, H. K., Benedetti, L., Sanzgiri, Y. D., Topp, E. M., and Stella, V.J., Ocular sustained delivery of prednisolone using hyaluronic acid benzyl ester films, Int. J. Pharm., 111, 295, 1994.
113. Illum, L., Farraj, N. F., Fisher, A. N., Gill, I., Miglietta, M., and Benedetti, L. M., Hyaluronic acid ester microspheres as a nasal delivery system for insulin, J. Controlled Rel., 29, 133, 1994.
114. Richardson, J. L., Ramires, P. A., Miglietta, M. R., Rochira, M., Bacelle, L., Callegaro, L., and Benedetti, L., Novel vaginal delivery systems for calcitonin: I. Evaluation of HYAFF/calcitonin microspheres in rats, Int. J. Pharm., 115, 9, 1995.
115. Bonucci, E., Ballanti, P., Ramires, P. A., Richardson, J. L., and Benedetti, L. M., Prevention of ovariectomy osteopenia in rats after vaginal administration of Hyaff 11 microspheres containing salmon calcitonin, Calcif. Tissue Int., 56, 274, 1995.
116. Knudson, C. B. and Knudson, W., Hyaluronan-Binding proteins in development, tissue homeostasis, and disease, FASEB J., 7, 1233, 1993.
117. Sherman, L., Sleeman, J., Herrlich, P., and Ponta, H., Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression, Curr. Opin. Cell Biol., 6, 726, 1994.
118. Lesley, J., Hyman, R., English, N., Catterall, J. B., and Turner, G. A., CD44 in inflammation and metastasis, Glycoconj. J. 14, 611, 1997.
119. Griffioen, A. W., Coenen, M. J. H., Damen, C. A., Hellwig, S. M. M.,van Weering, D. H. J., Vooys, W., Blijham, G. H., and Groenewegen, G., CD44 is involved in tumor angiogenesis: An activation antigen on human endothelial cells, Blood, 90, 1150, 1997.
120. Deed, R., Rooney, P., Kumar, P., Norton, J. D., Smith, J., Freemont, A.J., and Kumar, S., Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells: Inhibition by non-angiogenic, high-molecular-weight hyaluronan, Int. J. Cancer, 71, 251, 1997.
121. Montesano, R., Kumar, S., Orci, L., and Pepper, M. S., Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro, Lab. Invest., 75, 249, 1996.
122. Trochon,V., Mabilat, C., Bertrand, P., Legrand, Y., Smadjajoffe, F., Soria, C., Delpech, B., and Lu, H., Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro, Inf. J. Cancer, 66, 664, 1996.
123. Rooney, P., Kumar, S., Ponting, J., and Wang, M., The role of hyaluronan in tumour neovascularization (review), Int. J. Cancer, 60, 632, 1995.
124. West, D. C., Hampson, I. N., Arnold, F., and Kumar, S., Angiogenesis induced by degradation products of hyaluronic acid, Science, 228, 1324, 1985.
125. Koochekpour, S., Pilkington, G. J., and Merzak, A., Hyaluronic acid/CD44H interaction induces cell detachment and stimulates migration and invasion of human glioma cells in vitro, Int. J. Cancer, 63, 450, 1995.
126. Nakagawa, T., Kubota, T., Kabuto, M., and Kodera, T., Hyaluronic acid facilitates glioma cell invasion in vitro, Anticancer Res., 16, 2917, 1996.
127. Culty, M., Shizari, M., Thompson, E. W., and Underhill, C. B., Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: Correlation with invasive potential, J. Cell. Physiol., 160, 275, 1994.
128. Ropponen, K., Tammi, M., Parkkinen, J., Eskelinen, M., Tammi, R., Lipponen, P., Agren, U., Alhava, E., and Kosma, V. M., Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer, Cancer Res., 58, 342, 1998.
129. Catterall, J. B., Gardner, M. J., Jones, L. M. H., and Turner, G. A., Binding of ovarian cancer cells to immobilized hyaluronic acid, Glycoconj. J., 14, 647, 1997.
130. Baum, H.-P., Schmid, T., Schock, G., and Reichrath, J., Expression of CD44 isoforms in basal cell carcinomas, Br. J. Dermatol., 134, 465, 1996.
131. Yu, Q., Toole, B. P., and Stamenkovic, I., Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function, J. Exp. Med., 12, 1985, 1997.
132. Rockey, D. C., Chung, J. J., McKee, C. M., and Noble, P. W., Stimulation of inducible nitric oxide synthase in rat liver by hyaluronan fragments, Hepatology, 27, 86, 1998.
133. Croft, D. R., Dall, P., Davies, D., Jackson, D. G., McIntyre, P., and Kramer, I. M., Complex CD44 splicing combinations in synovial fibroblasts from arthritic joints, Eur. J. Immunol., 27, 1680, 1997.
134. Noble, P. W., Lake, F. R., Henson, P. M., and Riches, D. W. H., Hyaluronate activation of CD44 induces insulin-like growth factor-1 exprression by a tumor necrosis factor-α-dependent mechanism in murine macrophages, J. Clin. Invest., 91, 2368, 1993.
135. McKee, C. M., Penno, M. B., Cowman, M., Burdick, M. D., Stricter, R. M., Bao, C., and Noble, P. W., Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages: The role of HA size and CD44, J. Clin. Invest.,98, 2403, 1996.
136. McKee, C. M., Lowenstein, C. J., Horton, M. R., Wu, J., Bao, C., Chin, B. Y., Choi, A. M. K., and Noble, P. W., Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor κB-dependent mechanism, J. Biol. Chem., 272, 8013, 1997.
137. Noble, P. W., McKee, C. M., Cowman, M., and Shin, H. S., Hyaluronan fragments activate an NF-κB/I-κBα autoregulatory loop in murine macrophages, J. Exp. Med., 183, 2373, 1996.
138. Samuel, S. K., Hurta, R. A. R., Spearman, M. A., Wright, J. A., Turley, E. A., and Greenberg, A. H., TGF-β1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan, J. Cell Biol., 123, 749, 1993.
139. Hall, C. L., Wang, C., Lange, L. A., and Turley, E. A., Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity, J. Cell Biol., 126, 575, 1994.
140. Kornovski, B. S., McCoshen, J., Kredenster, J., and Turley, E., The regulation of sperm motility by a novel hyaluronan receptor, Fertil. Steril., 61, 935, 1994.
141. Gustafson, S., Bjorkman, T., and Westlin, J. E., Labelling of high molecular weight hyaluronan with i-125-tyrosine: studies in vitro and in vivo in the rat, Glycoconj. J., 11, 608, 1994.
142. Gustafson, S., Bjorkman, T., Forsberg, N., Lind, T., Wikstrom,T., and Lidholt, K., Accessible hyaluronan receptors identical to ICAM-1 in mouse mast-cell tumours, Glycoconj. J., 12, 350, 1995.